Dublin, Aug. 16, 2024 (GLOBE NEWSWIRE) -- The "Coronary Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.
Coronary stents market is poised for significant growth. Projections estimate robust growth with the market expected to ascend from its current valuation of USD 9.27 billion in 2023 to USD 14.28 billion by 2030, flourishing at a CAGR of 7.51%. This market expanse is underpinned by the heightened global prevalence of cardiovascular disorders including stroke, atherosclerosis, and heart attack.
Contributing Market Dynamics
Key dynamics propelling the market forward include an upsurge in the instances of cardiovascular diseases and a global demographic shift with an expanding elderly population. High-risk factors such as obesity and smoking also play a causal role in the burgeoning demand for coronary stents. However, factors such as product recalls and stringent regulatory approval processes could potentially impede market growth to a certain extent.
Detailed Segment Analysis and Geographical Insights
The market is segmented by product type, material, end-user, and geography. The drug-eluting segment shows a particularly promising growth trajectory due to their efficacy in reducing restenosis and stent thrombosis risks. Geographically, North America leads the market with expectations of continued dominance, attributed to strong healthcare infrastructure and favorable reimbursement conditions.
Competitive Landscape and Key Regional Players
The market is well-populated with key players like Medtronic and Abbott contributing to the innovation, development, and supply of advanced coronary stent products. Noteworthy developmental actions such as FDA approvals indicate an environment rife with innovation and a focus on enhancing patient outcomes.
Market Expectations and Future Outlook
With a multitude of factors at play, the coronary stents market is projected to witness substantial development and growth over the next decade. Health systems and patients globally may anticipate benefiting from advancements that are shaping the future of cardiovascular disease management.
The insights presented reflect the current trends observed in the coronary stents market and highlight the potential opportunities for various stakeholders within this sector. As cardiovascular diseases remain a pressing global health concern, coronary stents are likely to remain vital tools in the therapeutic armamentarium against these ailments.
A selection of companies mentioned in this report includes, but is not limited to:
- Medtronic
- Abbott
- Boston Scientific Corporation
- Biosensors International Group, Ltd.
- BIOTRONIK SE & Co. KG
- B. Braun Melsungen AG
- TERUMO CORPORATION
- STENTYS SA
- MicroPort Scientific Corporation
- Meril Life Sciences Pvt. Ltd
For more information about this report visit https://www.researchandmarkets.com/r/nwzpty
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
